Team AngelMD • October 21, 2016

This week’s #FounderFriday is Aakash Sur, CTO of miPS Labs. The Seattle-based biotechnology startup is the first and only company to offer consumers individualized cell cryopreservation in anticipation of stem cell therapies that are currently in development around the world, including treatments and potential cures for macular degeneration, heart disease, spinal cord injury, Parkinson’s disease and type 1 diabetes.  We are thrilled to have Aakash #tellyourstory and miPS Labs be a part of#thescienceofinvesting.



Aakash Surakon




miPS Labs

Where are you from:

Seattle, WA

What is your favorite restaurant to eat at for a business meeting:


What is the best book you have read in the last 6 months:

The Spy Who Came in from the Cold by  John le Carré

When I am not in the office, I am…..



Find the best in healthcare innovation. Join angelMD today.

miPS Labs